Actively Recruiting

Age: 1Year - 95Years
All Genders
Healthy Volunteers
NCT04217018

MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence

Led by The First Affiliated Hospital of Zhengzhou University · Updated on 2021-02-08

3000

Participants Needed

1

Research Sites

543 weeks

Total Duration

On this page

Sponsors

T

The First Affiliated Hospital of Zhengzhou University

Lead Sponsor

S

Sun Yat-sen University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This registry aims to collect clinical, molecular and radiologic data including detailed clinical parameters, molecular pathology (1p/19q co-deletion, MGMT methylation, IDH and TERTp mutations, etc) and conventional/advanced/new MR sequences (T1, T1c, T2, FLAIR, ADC, DTI, PWI, etc) of patients with primary gliomas. By leveraging artificial intelligence, this registry will seek to construct and refine algorithms that able to predict molecular pathology or subgroups of gliomas.

CONDITIONS

Official Title

MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence

Who Can Participate

Age: 1Year - 95Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients must have radiologically and histologically confirmed diagnosis of primary glioma
  • Life expectancy of greater than 3 months
  • Must receive tumor resection
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • No gliomas
  • No sufficient amount of tumor tissues for detection of molecular pathology
  • Patients who have any type of bioimplant activated by mechanical, electronic, or magnetic devices
  • Patients who are pregnant or breast feeding
  • Patients who are suffered from severe systematic malfunctions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Neurosurgery, First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China, 450052

Actively Recruiting

Loading map...

Research Team

Z

Zhenyu Zhang, Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence | DecenTrialz